FRANKLIN COVEY CO. Deferred Income Tax Expense (Benefit)
FRANKLIN COVEY CO. (FC) reported Deferred Income Tax Expense (Benefit) of $1.06 million for the 12-month period ending 2025-08-31, per its 10-K filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-11-12
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for the quarter ending 2012-08-31 was $1.42M.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for the quarter ending 2012-05-26 was $646.00K, a 39.17% decline year-over-year.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for the quarter ending 2012-02-25 was $662.00K, a 63.05% increase year-over-year.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for the quarter ending 2011-11-26 was $394.00K, a 68.80% decline year-over-year.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for fiscal 2025 was $1.06M, a 39.77% decline from fiscal 2024.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for fiscal 2024 was $1.75M, a 64.24% decline from fiscal 2023.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for fiscal 2023 was $4.91M, a 2226.07% increase from fiscal 2022.
- FRANKLIN COVEY CO. deferred income tax expense (benefit) for fiscal 2022 was $211.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-08-31 | $1.06M 10-K · filed 2025-11-12 | |||
| 2024-08-31 | $1.75M 10-K · filed 2025-11-12 | |||
| 2023-08-31 | $4.91M 10-K · filed 2025-11-12 | |||
| 2022-08-31 | $211.00K 10-K · filed 2024-11-12 | |||
| 2021-08-31 | -$9.61M 10-K · filed 2023-11-13 | |||
| 2020-08-31 | $8.98M 10-K · filed 2022-11-14 | |||
| 2019-08-31 | -$1.05M 10-K · filed 2021-11-12 | |||
| 2018-08-31 | -$2.34M 10-K · filed 2020-11-16 | |||
| 2017-08-31 | -$6.06M 10-K · filed 2019-11-14 | |||
| 2016-08-31 | $1.76M 10-K · filed 2018-11-14 | |||
| 2015-08-31 | $3.18M 10-K · filed 2017-11-14 | |||
| 2014-08-31 | $1.23M 10-K · filed 2016-11-14 | |||
| 2013-08-31 | $299.00K 10-K · filed 2015-11-13 | |||
| 2012-08-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-14 | $2.07M derived: sum of 2 quarters · filed 2014-11-14 | $2.73M derived: sum of 3 quarters · filed 2014-11-14 | $3.13M 10-K · filed 2014-11-14 |
| 2012-05-26 | $646.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-03 | $1.31M derived: sum of 2 quarters · filed 2012-07-03 | $1.70M 10-Q · filed 2012-07-03 | $763.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-02-25 | $662.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-04-04 | $1.06M 10-Q · filed 2012-04-04 | $117.00K derived: sum of 3 quarters · filed 2013-11-14 | $1.18M derived: sum of 4 quarters · filed 2013-11-14 |
| 2011-11-26 | $394.00K 10-Q/A · filed 2012-01-26 | -$545.00K derived: sum of 2 quarters · filed 2013-11-14 | $517.00K derived: sum of 3 quarters · filed 2013-11-14 | $923.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2011-08-31 | -$939.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-14 | $123.00K derived: sum of 2 quarters · filed 2013-11-14 | $529.00K derived: sum of 3 quarters · filed 2013-11-14 | $1.79M 10-K · filed 2013-11-14 |
| 2011-05-28 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-03 | $1.47M derived: sum of 2 quarters · filed 2012-07-03 | $2.73M 10-Q · filed 2012-07-03 | |
| 2011-02-26 | $406.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-04-04 | $1.67M 10-Q · filed 2012-04-04 | ||
| 2010-11-27 | $1.26M 10-Q/A · filed 2012-01-26 | |||
| 2010-08-31 | $1.37M 10-K · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |